BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 28071)

  • 21. [Antihypertensive therapy with a new beta-blocking agent Timolol. Double blind study and comparison with Alprenolol and Pindolol (author's transl)].
    Wessels F; Heinze A; Werth HW
    Med Klin; 1977 Oct; 72(41):1689-95. PubMed ID: 335203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of antihypertensive efficacy: propranolol versus oxprenolol in accelerated hypertension.
    Fernandez PG; Sharma JN; Galway AB; Kim BK; Granter S; Zachariah PK
    Pharmatherapeutica; 1982; 3(3):153-6. PubMed ID: 6752962
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of beta 1-selective and non-selective beta-blockade on blood pressure, plasma renin activity and plasma aldosterone in hypertensive patients.
    van Herwaarden CL; Fennis JF; van 'T Laar A
    Neth J Med; 1979; 22(1):17-22. PubMed ID: 368667
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effect of celiprolol compared to propranolol on thyroid metabolism].
    Langsteger W; Lind P; Eber O
    Wien Med Wochenschr; 1985 Sep; 135(18):451-7. PubMed ID: 2865857
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.
    El Mehairy MM; Shaker A; Ramadan M; Hamza S; Tadros SS
    J Int Med Res; 1980; 8(3):193-8. PubMed ID: 6104614
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic and adrenergic responses of bevantolol and propranolol in hypertensives.
    Snedden W; Fernandez PG; Vasdev S; Bolli P
    Can J Cardiol; 1989; 5(1):37-41. PubMed ID: 2563955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Studies with prazosin--a new effective hypotensive agent. III. An acute double-blind cross-over study comparing the effects of single doses of prazosin and hydrallazine in combination with propranolol and a diuretic.
    Hua AS; Myers JB; Kincaid-Smith P
    Med J Aust; 1978 Jan; 1(1):45-8. PubMed ID: 368538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single daily dose penbutolol in the treatment of hypertension: a double blind crossover comparison with propranolol.
    Kubik MM; Hanks GW
    Eur J Clin Pharmacol; 1980 Jun; 17(6):409-13. PubMed ID: 6995132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind trial of penbutolol: a new beta-receptor blocking agent in the treatment of angina pectoris.
    Agarwal AK; Ahuja RC; Chandra M; Gupta NN; Hasan M
    J Int Med Res; 1976; 4(6):410-7. PubMed ID: 17557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparison of timolol and propranolol in essential hypertension.
    Lohmöller G; Frohlich ED
    Am Heart J; 1975 Apr; 89(4):437-42. PubMed ID: 234668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bevantolol vs propranolol: a double-blind controlled trial in essential hypertension.
    Maclean D
    Angiology; 1988 Jun; 39(6):487-96. PubMed ID: 2897812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of clinical usefulness of beta-blocker in aged and younger essential hypertension. Double blind trial using bunitrolol].
    Kuramoto K; Ikeda M; Arakawa K; Inagaki Y; Kaneko Y; Masuyama Y; Yamazaki N; Tsuchiya M
    Nihon Ronen Igakkai Zasshi; 1984 Jan; 21(1):20-6. PubMed ID: 6145808
    [No Abstract]   [Full Text] [Related]  

  • 33. The comparative effects of ICI 118551 and propranolol on essential tremor.
    Jefferson D; Wharrad HJ; Birmingham AT; Patrick JM
    Br J Clin Pharmacol; 1987 Dec; 24(6):729-34. PubMed ID: 2894217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long term treatment of moderate hypertension with penbutolol (Hoe 893d). I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise.
    Hansson BG; Hökfelt B
    Eur J Clin Pharmacol; 1975 Oct; 9(1):9-19. PubMed ID: 9298
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of betaxolol, a new beta 1-adrenergic antagonist, to propranolol in the treatment of mild to moderate hypertension.
    Davidov ME; Glazer N; Wollam G; Zager PG; Cangiano J
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):206S-210S. PubMed ID: 2901266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between adrenergic blocking and antihypertensive effects of beta receptor antagonists.
    Rahn KH
    Adv Clin Pharmacol; 1976; 11():14-8. PubMed ID: 25567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison between metoprolol and propranolol as antihypertensive agents. A double-blind cross-over study.
    Bengtsson C
    Acta Med Scand; 1976; 199(1-2):71-4. PubMed ID: 3094
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.
    Giudicelli JF; Richer C; Chauvin M; Idrissi N; Berdeaux A
    Br J Clin Pharmacol; 1977 Apr; 4(2):135-40. PubMed ID: 16632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of penbutolol and propranolol on glomerular filtration rate in hypertensive patients with impaired renal function.
    van der Meulen J; Reijn E; Heidendal GA; Oe PL; Donker AJ
    Br J Clin Pharmacol; 1986 Oct; 22(4):469-74. PubMed ID: 3533129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Left ventricular function and beta-blockade in chronic ischaemic heart failure. Double-blind, cross-over study of propranolol and penbutolol using non-invasive techniques.
    Vedin A; Wikstrand J; Wilhelmsson C; Wallentin I
    Br Heart J; 1980 Jul; 44(1):101-7. PubMed ID: 7000099
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.